Moffitt Cancer Center researchers have developed a novel reagent that enhances the precision of drug synthesis. This innovative method, published in Nature Communications, introduces a new sulfur fluoride exchange (SuFEx) ...
Aug 17, 2024
0
17
Personalized medicine is transforming cancer treatment by tailoring therapies to the genomic profile of each tumor. Next-generation sequencing (NGS) is key to this approach, but its complexity and inconsistent reporting have ...
Aug 16, 2024
0
0
A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients.
Aug 15, 2024
0
0
Researchers at the University of Chemistry and Technology in Prague together with colleagues from Military Health Institute and Prague Water Supply and Sewerage Company have successfully utilized nanopore-based sequencing ...
Aug 15, 2024
0
0
A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the SARS-CoV-2 coronavirus in pregnant women.
Aug 13, 2024
0
1
Dr. Sabine Mai, Canada Research Chair in Genomic Instability and Nuclear Architecture of Cancer with the Rady Faculty of Health Sciences recently co-authored an article published in the American Journal of Hematology. The ...
Aug 9, 2024
0
16
From costing society an estimated $11 trillion to hindering new discoveries in medicine and preventing access to effective interventions, underrepresentation of women, older adults and minorities in clinical research has ...
Aug 8, 2024
0
0
Researchers at Osaka University identified problems in access and use of oral contraceptives among transnational Japanese patients created by different perceptions from physicians. The findings revealed the clinical and ethical ...
Aug 5, 2024
0
0
The Australian National Health and Medical Research Council (NHMRC) has just released its much-anticipated landmark statement advocating for sex, gender, variations of sex characteristics and sexual orientation to be routinely ...
Aug 4, 2024
0
0
Scientists at St. Jude Children's Research Hospital have created a panel that is able to provide a diagnosis for more than 90% of pediatric cancer patients by sequencing 0.15% of the human genome. The panel is a cost-effective ...
Aug 2, 2024
0
0
